Apollo Therapeutics
Apollo Therapeutics is a biotech company. It has raised $260.0M across 2 rounds, most recently a $33.5M Extension Round in January 2024.
Breakthrough science | Portfolio business
- Website
- apollotx.com
- Total Funding
- $260.0M
- Last Round
- $33.5M Extension RoundJan 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
Biopharmaceutical company advancing therapeutic programs
Summary
It has raised $260.0M in total across 2 rounds, most recently a $33.5M Extension Round in Jan 2024. Investors include Patient Square Capital, Invus and Rock Springs Capital.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2024
Sign up to see all 2 events
Funding: Series C through Extension Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/apollo-therapeutics"><img src="https://indexed.vc/api/badge/company/apollo-therapeutics" alt="Apollo Therapeutics on Indexed.vc" width="260" height="76" /></a>